RETRACTED: Tumor dependence on the EGFR signaling pathway expressed by the p-EGFR:p-AKT ratio predicts erlotinib sensitivity in human non-small cell lung cancer (NSCLC) cells expressing wild-type EGFR gene.

Abstract excerpt

The Journal of Thoracic Oncology was alerted on August 16, 2021 that Figures 1 and 3 in this article are suspected of image manipulation. The editorial team promptly consulted with the authors and publisher. The authors stand by the validity of the conclusions and the scientific merit of the manuscript but acknowledge that some Figures might not have been properly prepared. Therefore, the editorial team asserts...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to DNA, Neoplasm
• Share to Dose-Response Relationship, Drug